Teva Women's Health, LLC Sustainability Profile
Teva Women's Health, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2015, the company has quickly established itself as a leader in women's health, focusing on innovative solutions that address the unique healthcare needs of women. With a strong operational presence across North America, Teva Women's Health is dedicated to providing high-quality products and services that enhance women's health and well-being. The company’s core offerings include a range of contraceptive options and treatments for various gynaecological conditions, distinguished by their commitment to safety and efficacy. Teva Women's Health has achieved notable milestones, including the successful launch of several key products that have significantly impacted the market. As a subsidiary of Teva Pharmaceutical Industries, the company benefits from a robust global network, positioning it as a trusted name in women's healthcare.
DitchCarbon Score
How does Teva Women's Health, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Teva Women's Health, LLC's score of 82 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Teva Women's Health, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Teva Pharmaceutical Industries Limited, which means any emissions data or climate commitments would be inherited from this parent organisation. Teva Pharmaceutical Industries Limited has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Teva Women's Health, LLC are not detailed in the available information. As a subsidiary, Teva Women's Health aligns with the broader climate commitments of its parent company, which focuses on reducing emissions across its operations. The absence of specific emissions data suggests that the company is still in the process of developing its own detailed climate strategy or reporting framework. In summary, while Teva Women's Health, LLC does not currently report specific emissions figures or reduction targets, it is part of a larger corporate family that is actively engaged in climate initiatives and emissions reduction efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 438,420,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 613,541,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Teva Women's Health, LLC's Industry?
How Carbon Intensive is Teva Women's Health, LLC's Location?
Teva Women's Health, LLC's Scope 3 Categories Breakdown
Teva Women's Health, LLC's Scope 3 emissions, which decreased by 6% last year and decreased by approximately 24% since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 61% of Scope 3 emissions.
Top Scope 3 Categories
Teva Women's Health, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Teva Women's Health, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
